Quick Facts: Tylenol
| Current Owner | Kenvue Inc. (NYSE: KVUE) |
| Ownership Type | Public (pending acquisition) |
| Spun Off From | Johnson & Johnson, 2023 |
| Pending Acquirer | Kimberly-Clark Corporation |
| Deal Value | $48.7 billion |
| Shareholder Approval | January 2026 |
| Expected Close | Second half of 2026 |
Who Owns Tylenol?
Tylenol is currently owned by Kenvue Inc., the consumer health company that Johnson & Johnson spun off as an independent public company in 2023, separating its consumer brands from its pharmaceutical and medical device businesses.
That independence is set to be short-lived: Kimberly-Clark agreed to acquire Kenvue on November 2, 2025, in a deal valued at approximately $48.7 billion, bringing Tylenol together with Kimberly-Clark’s Huggies and Kleenex brands under one roof.
Shareholders of both companies overwhelmingly approved the deal in January 2026, and the required antitrust waiting period expired in February 2026, clearing most of the major regulatory hurdles. Under the terms, Kenvue shareholders will receive 0.14625 shares of Kimberly-Clark stock plus $3.50 in cash for each Kenvue share, with the combined company split roughly 54% Kimberly-Clark and 46% Kenvue ownership.
The deal is expected to close in the second half of 2026, pending remaining foreign regulatory approvals, at which point Tylenol will become part of Kimberly-Clark rather than remaining under the standalone Kenvue structure it has operated under since 2023.
Tylenol Ownership History
| Year | Event | Owner / Key Figure | Notes |
|---|---|---|---|
| 1955 | Tylenol brand launches | McNeil Laboratories | Acquired by Johnson & Johnson in 1959 |
| 1982 | Chicago tampering crisis | Johnson & Johnson | Led to the industry’s tamper-proof packaging standard |
| 2023 | Kenvue spun off as independent company | Kenvue Inc. | Separated from J&J’s pharma/medtech business |
| 2025–2026 | Kimberly-Clark acquisition, $48.7 billion | Kimberly-Clark (pending) | Shareholders approved Jan. 2026; expected close H2 2026 |
About Kenvue & Kimberly-Clark
Kenvue was created specifically to house Johnson & Johnson’s consumer brands — including Tylenol, Band-Aid, Listerine, Neutrogena, and Aveeno — as a standalone public company, separate from J&J’s higher-margin pharmaceutical and medical device operations.
Kimberly-Clark, the maker of Huggies and Kleenex, is pursuing the acquisition to build a broader consumer staples giant, with the companies projecting roughly $1.9 billion in cost synergies over the first three years following the deal’s close.
Key Ownership Highlights
- Tylenol has changed corporate parents twice in recent years: from Johnson & Johnson directly, to independent Kenvue in 2023, and soon to Kimberly-Clark once the pending deal closes.
- The Kimberly-Clark deal is one of the largest consumer-goods acquisitions in years: $48.7 billion, combining two major household-name portfolios.
- Shareholder approval and antitrust clearance are already complete: as of January and February 2026 respectively, leaving only foreign regulatory sign-offs before closing.
- The 1982 tampering crisis remains a landmark case in the brand’s history: Johnson & Johnson’s handling of it became a widely cited example of crisis management, and it reshaped over-the-counter drug packaging industry-wide.
- Kenvue’s independence as a standalone company will have lasted only about three years: spun off in 2023, with the Kimberly-Clark deal expected to close in 2026.
Frequently Asked Questions
Who owns Tylenol right now?
Kenvue Inc., the consumer health company spun off from Johnson & Johnson in 2023.
Is Tylenol being sold to a new company?
Yes, Kimberly-Clark agreed to acquire Kenvue for $48.7 billion; the deal has shareholder and antitrust approval and is expected to close in the second half of 2026.
Is Johnson & Johnson still connected to Tylenol?
No, J&J fully separated its consumer health business, including Tylenol, into the independent Kenvue in 2023.
What other brands are part of this deal?
Kenvue also owns Band-Aid, Listerine, Neutrogena, and Aveeno; Kimberly-Clark owns Huggies and Kleenex.
When was Tylenol first developed?
The brand launched in 1955 through McNeil Laboratories, which Johnson & Johnson acquired in 1959.
